Table 1.
Assessment | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 |
---|---|---|---|---|---|---|
Sex | M | F | F | M | M | M |
Age | 76 | 66 | 49 | 56 | 70 | 74 |
Date to admitting | 11 | 15 | 7 | 8 | 6 | 3 |
Previous history | BPH and COPD | No | No | No | No | BPH and COPD |
Personal history | Smoking | No | No | Smoking Alcohol consumption | No | Smoking |
Initial symptom | Epilepsy | Epilepsy | Epilepsy | Epilepsy | Epilepsy | Behavior disorder |
Other symptom | Memory deficit | No | Memory deficit Cognitive decline | Behavior disorder Cognitive decline | Behavior disorder Cognitive decline | Status epilepticus Cognitive decline |
CSF Pressure (mmH2O)* | 123 | 108 | 158 | 162 | 150 | 250 |
Leukocyte in CSF† | 16 *106/L | 17 *106/L | 35 *106/L | 56 *106/L | 13 *106/L | 15 *106/L |
Protein in CSF‡ | 510 mg/L | 840 mg/L | 290 mg/L | 480 mg/L | 530 mg/L | 550 mg/L |
CSF antibody titer | 1:100 | 1:32 | 1:320 | 1:32 | 1:32 | 1:32 |
Serum antibody titer | 1:32 | 1:10 | 1:32 | 1:10 | 1:32 | 1:10 |
Other antibody in CSF or Serum | Anti-Ma 2 antibody in Serum | No | No | No | No | No |
D-dimmer§ | 1.1 mg/L | 1.72 mg/L | 0.51 mg/L | 0.42 mg/L | 0.31 mg/L | 0.54 mg/L |
Tumor maker | No | No | No | No | No | No |
Tumors | Suspected testicular cancer | small cell cancer | No | small cell lung cancer | Esophagus cancer | No |
Lesions on brain MRI | Left frontal lobe, guide lobe, temporal lobe and hippocampus | Bilateral guide lobe, frontal parietal lobe and basal ganglia | No lesions | Right hippocampus | Bilateral hippocampus | unchecked |
EEG | Normal | Abnormal | Abnormal | Normal | Normal | Abnormal |
Corticosteroid pulse therapy | Yes | Yes | Yes | Yes | Yes | Yes |
IVIg | No | No | No | No | Yes | Yes |
AEDs treatment in hospital | VPA and LEV | VPA and LEV | VPA | VPA and LEV | LEV | VPA and LEV |
mRS score at admission | 4 | 3 | 3 | 4 | 4 | 5 |
mRS score at discharge | 1 | 2 | 0 | 0 | 4 | 6# |
mRS score at 6 mo after onset | 0 | 0 | 0 | 0 | 3 | NA |
Residual symptoms at discharge | No | No | No | No | Cognitive decline | NA |
treatment after discharge | Prednisone and LEV | No | No | Prednisone and LEV | Prednisone and LEV | NA |
AEDs = antiepileptic drug, anti-GABAB = Anti-gamma-aminobutyric acid B, BPH = benign prostatic hyperplasia, COPD = chronic obstructive pulmonary disease, CSF = cerebrospinal fluid, EEG = electroencephalography, IVIg = intravenous immunoglobulin, LEV = levetiracetam, MRI magnetic resonance imaging, mRS = modified Rankin scores, NA = not available, VPA = valproic acid.
normal range of CSF Pressure: 80-180 mmH2O,
normal range of CSF leukocyte count: 0-6 × 106/L,
normal range of CSF proteins: 150-450 mg/L,
normal range of D-dimmer: 0-0.55 mg/L FEU,
# death.